Clindamycin Palmitate Hydrochloride
NDC 62135-926, Clindamycin Palmitate Hydrochloride, granule, for solution, from Chartwell RX, LLC.
- Product NDC
- 62135-926
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- GRANULE, FOR SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206958
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-926 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLINDAMYCIN PALMITATE HYDROCHLORIDE75 mg/5mL
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Lincosamide Antibacterial [EPC]; Lincosamides [CS]; Neuromuscular Blockade [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-926-01 | 62135092601 | 100 mL in 1 BOTTLE (62135-926-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5d120b48-8181-4f40-a0e5-1f5cd0450d4f
Use it
Look up 62135-926 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-926 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-926. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.